Xiaohan Zhou, Kun Shi, Ying Hao, Chengli Yang, Ruoyu Zha, Cheng Yi, & Zhiyong Qian. (2020). Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy. Elsevier.
Chicago Style (17th ed.) CitationXiaohan Zhou, Kun Shi, Ying Hao, Chengli Yang, Ruoyu Zha, Cheng Yi, and Zhiyong Qian. Advances in Nanotechnology-based Delivery Systems for EGFR Tyrosine Kinases Inhibitors in Cancer Therapy. Elsevier, 2020.
MLA (9th ed.) CitationXiaohan Zhou, et al. Advances in Nanotechnology-based Delivery Systems for EGFR Tyrosine Kinases Inhibitors in Cancer Therapy. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.